The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex
Open accessAbstract
Calcineurin, which binds to the Z-disc in cardiomyocytes via alpha-actinin, promotes cardiac hypertrophy in response to numerous pathologic stimuli. However, the endogenous mechanisms regulating calcineurin activity in cardiac muscle are not well understood. We demonstrate that a muscle-specific F-box protein called atrogin-1, or muscle atrophy F-box, directly interacts with calcineurin A and alpha-actinin-2 at the Z-disc of cardiomyocytes. Atrogin-1 associates with Skp1, Cul1, and Roc1 to assemble an SCF(atrogin-1) complex with ubiquitin ligase activity. Expression of atrogin-1 decreases levels of calcineurin A and promotes its ubiquitination. Moreover, atrogin-1 attenuates agonist-induced calcineurin activity and represses calcineurin-dependent transactivation and NFATc4 translocation. Conversely, downregulation of atrogin-1 using adenoviral small interfering RNA (siRNA) expression enhances agonist-induced calcineurin activity and cardiomyocyte hypertrophy. Consistent with these cellular observations, overexpression of atrogin-1 in hearts of transgenic mice reduces calcineurin protein levels and blunts cardiac hypertrophy after banding of the thoracic aorta. These studies indicate that the SCF(atrogin-1) ubiquitin ligase complex interacts with and represses calcineurin by targeting calcineurin for ubiquitin-mediated proteolysis, leading to inhibition of cardiac hypertrophy in response to pathologic stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,637
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., & Harper, J. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80403-1 · Cited by 1,224
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, H., Zhu, W., Bassel-Duby, R., & Williams, R. S. (1998) · Genes & Development · doi:10.1101/gad.12.16.2499 · Cited by 1,011
Ballinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L.-Y., & Patterson, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4535 · Cited by 943
Self-citationHypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Feldman, R. M. R., Correll, C. C., Kaplan, K. B., & Deshaies, R. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80404-3 · Cited by 808
Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Prognostic implications of left ventricular hypertrophy
Vakili, B. A., Okin, P. M., & Devereux, R. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113218 · Cited by 712
Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Gattobigio, R., Zampi, I., Reboldi, G., & Porcellati, C. (1998) · Circulation · doi:10.1161/01.cir.97.1.48 · Cited by 655
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases
Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., & Reimann, J. D. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01834-1 · Cited by 634
Association of Protein Kinase A and Protein Phosphatase 2B with a Common Anchoring Protein
Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M., & Scott, J. D. (1995) · Science · doi:10.1126/science.7528941 · Cited by 617
CHIP Is a U-box-dependent E3 Ubiquitin Ligase
Jiang, J., Ballinger, C. A., Wu, Y., Dai, Q., Cyr, D. M., Höhfeld, J., & Patterson, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101968200 · Cited by 593
Self-citationTissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.
Subramaniam, A., Jones, W. K., Gulick, J., Wert, S., Neumann, J., & Robbins, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54273-3 · Cited by 469
Stress Pathways and Heart Failure
Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80043-4 · Cited by 446
How the Cyclin Became a Cyclin
Koepp, D. M., Harper, J. W., & Elledge, S. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80753-9 · Cited by 445
Rothermel, B., Vega, R. B., Yang, J., Wu, H., Bassel-Duby, R., & Williams, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8719 · Cited by 414
Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 377
Delling, U., Turečková, J., Lim, H. W., Windt, L. J. D., Rotwein, P. S., & Molkentin, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6600-6611.2000 · Cited by 321
CHIP activates HSF1 and confers protection against apoptosis and cellular stress
Dai, Q. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg529 · Cited by 320
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309 · cited 1×
“racic aortic constriction was performed as described previously (54).”
MethodCalsarcins, a novel family of sarcomeric calcineurin-binding proteins
Frey, N., Richardson, J. A., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501097 · Cited by 302
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Apoptosis of T Cells Mediated by Ca 2+ -Induced Release of the Transcription Factor MEF2
Youn, H.-D., Sun, L., Prywes, R., & Liu, J. O. (1999) · Science · doi:10.1126/science.286.5440.790 · Cited by 258
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
A transgenic mouse model of the ubiquitin/proteasome system
Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234
Calcineurin and Beyond: Cardiac Hypertrophic Signaling
Molkentin, J. D. (2000) · Circulation Research · doi:10.1161/01.res.87.9.731 · Cited by 229
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang, Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031371998 · Cited by 202
Jones, W. K., Grupp, I. L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T. E., Boivin, G., Gulick, J., Ng, W. A., & Robbins, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118992 · Cited by 200
Jackson, P. K., & Eldridge, A. G. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00538-5 · Cited by 187
Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy
Lim, H. W., De Windt, L. J., Steinberg, L., Taigen, T., Witt, S. A., Kimball, T. R., & Molkentin, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.20.2431 · Cited by 158
Multiple Domains of MCIP1 Contribute to Inhibition of Calcineurin Activity
Vega, R. B., Yang, J., Rothermel, B. A., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200123200 · Cited by 147
Control of Cardiac Growth and Function by Calcineurin Signaling
Vega, R. B., Bassel‐Duby, R., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300023200 · Cited by 132
Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Hill, J. A., Rothermel, B. A., Yoo, K., Cabuay, B. M., Demetroulis, E., Weiss, R. M., Kutschke, W. J., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110722200 · Cited by 119
Interaction of PKN with α-Actinin
Mukai, H., Toshimori, M., Shibata, H., Takanaga, H., Kitagawa, M., Miyahara, M., Shimakawa, M., & Ono, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4740 · Cited by 117
van Rooij, E., Doevendans, P. A., Crijns, H. J. G. M., Heeneman, S., Lips, D. J., van Bilsen, M., Williams, R. S., Olson, E. N., Bassel‐Duby, R., Rothermel, B. A., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000118597.54416.00 · Cited by 116
Pu, W. T., Ma, Q., & Izumo, S. (2003) · Circulation Research · doi:10.1161/01.res.0000069211.82346.46 · Cited by 102
Regulation of calcineurin by phosphorylation
Hashimoto, Y., & Soderling, T. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84738-5 · Cited by 98
Bush, E. W., Fielitz, J., Melvin, L., Arnold, M., McKinsey, T. A., Plichta, R. P., & Olson, E. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308723101 · Cited by 94
Ohta, T., & Xiong, Y. (2001) · PubMed · Cited by 66
Freeman, J. L. R., Pitcher, J. A., Li, X., Bennett, V., & Lefkowitz, R. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01543-x · Cited by 41
Yang, G., Meguro, T., Hong, C., Asai, K., Takagi, G., Karoor, V., Sadoshima, J., Vatner, D. E., Bishop, S. P., & Vatner, S. F. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1413 · Cited by 36
Cited by
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Mechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113
Metadata
- Authors
- Li, H.-H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-10-15
- Volume
- 114
- Issue
- 8
- Pages
- 1058-1071
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2103822936
- Cited by
- 430
- References
- 52
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.